Roosevelt Investment Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,479
Closed -$216K 190
2017
Q3
$216K Buy
+1,479
New +$201K 0.02% 178
2017
Q2
Sell
-2,319
Closed -$289K 204
2017
Q1
$289K Sell
2,319
-2,248
-49% -$269K 0.03% 174
2016
Q4
$529K Sell
4,567
-5,979
-57% -$666K 0.05% 137
2016
Q3
$1.1M Sell
10,546
-4,073
-28% -$441K 0.09% 104
2016
Q2
$1.44M Sell
14,619
-3,239
-18% -$335K 0.11% 94
2016
Q1
$1.79M Sell
17,858
-189,319
-91% -$19.5M 0.16% 86
2015
Q4
$24.8M Sell
207,177
-17,634
-8% -$2.04M 1.63% 22
2015
Q3
$24.3M Sell
224,811
-1,933
-0.9% -$240K 1.58% 23
2015
Q2
$26.2M Buy
226,744
+39,635
+21% +$4.53M 1.55% 20
2015
Q1
$21.6M Sell
187,109
-99,634
-35% -$11.9M 1.18% 34
2014
Q4
$32.1M Sell
286,743
-123,179
-30% -$13M 1.79% 19
2014
Q3
$38.9M Sell
409,922
-268,747
-40% -$24.3M 2.07% 18
2014
Q2
$58.3M Sell
678,669
-481
-0.1% -$36.6K 2.48% 13
2014
Q1
$47.4M Sell
679,150
-14,980
-2% -$1.19M 2.19% 18
2013
Q4
$58.6M Sell
694,130
-46,082
-6% -$3.65M 2.65% 12
2013
Q3
$57M Sell
740,212
-53,462
-7% -$3.75M 2.53% 9
2013
Q2
$46.4M Buy
+793,674
New +$47.8M 2.08% 16

Other funds holding CELG

Roosevelt Investment Group's CELG Position: Q4 2017 in Review

Roosevelt Investment Group sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,479 shares — an estimated $216K sold.

Roosevelt Investment Group first reported a position in CELG in Q2 2013 and held it in 17 quarters. The position peaked at $58.6M in Q4 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Roosevelt Investment Group reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Roosevelt Investment Group sold 1,479 Celgene Corp shares in Q4 2017, an estimated $216K.
  • Roosevelt Investment Group first reported a position in Celgene Corp in Q2 2013 and held it in 17 quarters.
  • Roosevelt Investment Group's Celgene Corp position peaked at $58.6M in Q4 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Roosevelt Investment Group's 13F filing for Q4 2017, filed 8 Feb 2018.